The global upper respiratory tract infection (URTI) treatment market is poised for steady growth, driven by the increasing prevalence of respiratory infections such as the common cold, sinusitis, and pharyngitis. The demand for effective therapeutic solutions—including antibiotics, antivirals, decongestants, and combination therapies—is rising due to seasonal outbreaks and...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt